We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts Question FDA's New Office Of Integrity and Accountability
Experts Question FDA's New Office Of Integrity and Accountability
March 23, 2007
FDA Commissioner Andrew von Eschenbach’s establishment of a new Office of Integrity and Accountability to address cultural issues within the agency might be a “nice” idea but is not necessary for accomplishing the FDA’s mission, according to Peter Pitts, director of the Center for Medicine in the Public Interest (CMPI).